Fibromyalgia treatment research

Terry H. Oh, M.D., Mayo Clinic associate professor of PM&R, discusses fibromyalgia research that was conducted with a database created from patients seen in the Fibromyalgia Treatment Program.

CREST-2 trial: Determining the best treatment for carotid atherosclerotic stenosis

Kevin M. Barrett, M.D., vascular neurologist at Mayo Clinic's campus in Florida, talks about the second phase of the international stroke trial and how to refer patients for participation. Dr. Barrett shares information about the seven-year ...

Chronic inflammation — From the beginning to the end

Anders Ekbom, M.D., Ph.D., presents chronic inflammation — from the beginning to the end.

2 fronts, 1 battle: Trauma surgery innovations

Donald Jenkins, M.D., Mayo Clinic trauma director, describes how collaboration between military and civilian trauma surgeons improves care for all patients.

Mesalamine dose may lower marker of bowel inflammation

Edward V. Loftus Jr., M.D., discusses an article looking at the ability of a drug to drive down calprotectin, a marker of bowel inflammation, in people who have ulcerative colitis.

Expanding Our Research Impact Through Dissemination and Implementation Thinking

Kasey Boehmer and Aaron Leppin, M.D. present Expanding Our Research Impact Through Dissemination and Implementation Thinking